Chimeric antigen receptor engineered innate immune cells in cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s11427-018-9451-0
Published Online: 2019-02-15
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Chu
Zhang, Jun
Text and Data Mining valid from 2019-02-15
Article History
Received: 17 October 2018
Accepted: 13 December 2018
First Online: 15 February 2019